BioInnovations 2004

2004
2005
2006
2007
2008
2009
2009
2010

MIT Sloan BioInnovations Conference Saturday, April 3, 2004

MIT Sloan School of Management
Kendall Square, Cambridge MA

Senior industry management, investors, and academics from the Massachusetts Biotechnology community convene for a day of substantive idea exchange.

The Agenda

8:00	Registration and Morning Networking
9:00	Opening Remarks Richard Schmalensee, John C Head III Dean of the MIT Sloan School of Management
	Introduction of Morning Keynote Speaker Martha L. Gray, Director, Harvard-MIT Division of Health Sciences & Technology, Edward Hood Taplin Professor of Medical and Electrical Engineering
	Opening Keynote Speaker Mark McClellan, Administrator of the Centers for Medicare and Medicaid Services/Outgoing FDA Commissioner
10:00	Networking
10:30	Technology panels with academic and industry viewpoints Genomics–Has the Bubble Burst or Have the Payoffs Only Just Begun? Panel Moderator David E. Housman, Ludwig Professor of Biology, MIT Department of Biology Panel Participants Alexander Kamb, VP & Global Head of Oncology Research, Novartis Institutes for Biomedical Research Todd Foley, Principal, MPM Capital Neuro-Imaging in Drug Development–Perspectives from the field Panel Moderator Randy Carpenter, CEO, Sention Pharmaceuticals Panel Participants Ashley Lawton, President, Descartes Therapeutics Gregory Sorenson, Associate Director, MGH Martinos NMR Center, Associate Professor of Radiology, Harvard Medical School Systems Biology–In Search of Governing Dynamics Panel Moderator Noubar Afeyan, Sr. Managing Director & CEO, Flagship Ventures Panel Participants Robert McBurney, CSO, Beyond Genomics Keith Elliston, CEO, Genstruct
12:00	Introduction of Lunchtime Keynote Speaker Kenneth P. Morse, Senior Lecturer and Managing Director, MIT Entrepreneurship Center Lunchtime Keynote Speaker Robert Langer, Germeshausen Professor, Chemical & Biomedical Engineering, MIT
12:45	Lunch
2:00	Policy panels with academic and industry viewpoints Developing and Managing Successful Global Health Partnerships Panel Moderator Dr. Ernst Berndt, Professor, MIT Sloan and NEBR Panel Participants Linda M. Distlerath, Vice President, Global Health Policy, Merck, Board Member of the African Comprehensive HIV/AIDS Partnerships Wendy Taylor, Executive Director, Bio Ventures for Global Health Balancing Patient Privacy and Innovation–Where do we go from here? Panel Moderator Martha L. Gray, Director, Harvard-MIT Division of Health Sciences & Technology, Edward Hood Taplin Professor of Medical and Electrical Engineering Panel Participants Heidi R. Wyle, Founding CEO, Computational Biology Corporation, Founder & Board Member, Ardais Corporation Cynthia A. Fisher, Founder & CEO, BioMed 2020 Technologies Stephen W. Bernstein, Partner, McDermott, Will & Emery The Path to Drug Approval–Current Regulatory Issues Panel Moderator Kenneth I. Kaitin, Director, Tufts Center for the Study of Drug Development Panel Participants Robert G. Pietrusko, Senior Vice President, Worldwide Regulatory Affairs & Pharmacovigilance Millennium Pharmaceuticals Bonnie Goldmann, Senior Vice President, Global Regulatory Affairs and Quality Assurance, Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD)
3:00	Networking
3:30	Afternoon Industry Executive Panel Idea to Product in the Healthcare Industry–What will the value chain look like in 2014? Panel Moderator Peter A. Tollman, Vice President & Director, Boston Consulting Group Panel Participants Alan Crane, CEO, Momenta Pharmaceuticals John Palmer, Senior Vice President, Corporate Development, Biogen Idec Rajiv Shukla, Director, Strategic Management Group, Pfizer Global Research & Development Lawrence Wittenberg, Partner, Business Practice Group, Testa, Hurwitz & Thibeault LLP
5:00	Networking